MedGen Inc (MDIN)

[Alien Trader]

Sorry I disagree with you on all of that.
Those of us who know how to run a retail and manufacturing business know the challenges that MDIN faces. We understand things get delayed and are out of the CEO’s control. Nick has done a great job with what he had to deal with coming into the job.

Everyone knows (At least experienced invest do) that a Pro Forma is a projection based on information at that time and nothing more. No investor should use that to make their investment in a company especially one on the OTC market. The deferred review was taken off the Qs because it was incorrectly list and was not yet realized. The CPA corrected that when he came on board. Doesn’t mean it’s not there.

Dealing with Retailers especially large BBs that control the market is not an easy thing to do and as we are starting to see more and more and coming on line for MDIN products. Get ready.